Skip to main content
Clinical Trials/NCT02917811
NCT02917811CompletedNot Applicable

Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU

Università degli Studi di Ferrara1 site in 1 country250 target enrollmentStarted: January 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
250
Locations
1
Primary Endpoint
90-days mortality

Study Overview

Brief Summary

The aim of this study is to verify if high values of RDW are useful prognostic marker for ICU mortality and 90-days mortality. Moreover, we will investigate the prognostic value of RDW in specific subgroup population with some clinical characteristic wich may modify RDW baseline values, i.e. transfused patients or patients with high markers of hemolysis

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Unselected ICU patients

Exclusion Criteria

  • Length of stay in ICU <48 hours
  • Hematological disease
  • Age <18 years

Outcomes

Primary Outcomes

90-days mortality

Time Frame: 90 days

Secondary Outcomes

  • ICU mortality(90 days)
  • Length of mechanical ventilation(90 days)

Investigators

Sponsor
Università degli Studi di Ferrara
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Savino Spadaro

MD

Università degli Studi di Ferrara

Study Sites (1)

Loading locations...

Similar Trials

Red Cell Distribution Width (RDW) as a... | Clinical Trial